| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 26.55B | 26.58B | 27.10B | 23.58B | 20.31B | 17.59B |
| Gross Profit | 7.88B | 7.86B | 8.15B | 6.79B | 5.97B | 5.05B |
| EBITDA | 2.73B | 3.01B | 3.50B | 2.66B | 2.29B | 1.83B |
| Net Income | 1.39B | 1.48B | 1.89B | 1.41B | 1.19B | 919.30M |
Balance Sheet | ||||||
| Total Assets | 35.42B | 35.99B | 34.01B | 30.68B | 25.52B | 22.32B |
| Cash, Cash Equivalents and Short-Term Investments | 4.90B | 4.85B | 4.47B | 3.12B | 3.60B | 4.30B |
| Total Debt | 12.69B | 12.74B | 10.52B | 9.58B | 6.48B | 6.15B |
| Total Liabilities | 18.82B | 18.76B | 17.99B | 16.72B | 12.97B | 10.92B |
| Stockholders Equity | 16.60B | 17.24B | 16.02B | 13.96B | 12.54B | 11.39B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.23B | 1.22B | -1.77B | -684.16M | 1.16B |
| Operating Cash Flow | 0.00 | -7.80M | 2.01B | -658.20M | 969.98M | 2.17B |
| Investing Cash Flow | 0.00 | -1.13B | -1.29B | -2.57B | -1.62B | -1.13B |
| Financing Cash Flow | 0.00 | 1.48B | 382.97M | 2.77B | -111.69M | 69.89M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥6.14T | 12.01 | ― | 4.06% | 0.40% | 8.40% | |
74 Outperform | ¥18.08B | 8.33 | ― | 3.29% | -1.36% | 5.14% | |
73 Outperform | ¥52.00B | 12.52 | ― | 2.76% | -10.66% | -38.53% | |
73 Outperform | ¥310.44B | 12.67 | ― | 2.99% | 0.31% | -11.04% | |
67 Neutral | ¥1.21T | 13.34 | 9.16% | 3.98% | -2.72% | 29.43% | |
65 Neutral | ¥3.04T | 14.08 | 7.55% | 2.22% | -3.22% | -29.63% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |